Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-12 of 12
Keywords: Phosphate binder
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron
Nephron (2024) 148 (1): 22–33.
Published Online: 20 July 2023
... to in the content or advertisements. 2023 Graphic Abstract Chronic kidney disease Hyperphosphataemia Phosphate binder Sucroferric oxyhydroxide Hyperphosphataemia is a key abnormality of chronic kidney disease-mineral and bone disorder (CKD-MBD), a common complication of CKD, which may...
Journal Articles
Todd Berner, Christine Ferro, Gabriela Dieguez, Steve Metz, Jennifer Moore, Erika Szabo, Csaba P. Kovesdy
Journal:
Nephron
Nephron (2023) 147 (10): 583–590.
Published Online: 30 March 2023
...Todd Berner; Christine Ferro; Gabriela Dieguez; Steve Metz; Jennifer Moore; Erika Szabo; Csaba P. Kovesdy Introduction: For patients with chronic kidney disease (CKD), the need for phosphate binder (PB) treatment peaks at onset of dialysis. This real-world study assessed rates of PB utilization...
Journal Articles
Subject Area:
Nephrology
Adrian C. Covic, Stuart M. Sprague, Anjay Rastogi, Markus Ketteler, Sebastian Walpen, Amandine Perrin, Jürgen Floege
Journal:
Nephron
Nephron (2020) 144 (9): 428–439.
Published Online: 25 June 2020
... dialysis patients treated with noncalcium, oral phosphate binder therapy in a phase 3 clinical trial. Methods: Post hoc analyses were performed using data for patients with hyperphosphatemia who received 52 weeks of treatment with sucroferric oxyhydroxide (SFOH) or sevelamer carbonate (sevelamer). Patients...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron
Nephron (2019) 142 (2): 135–146.
Published Online: 07 February 2019
... the importance of Pi regulation in the treatment of kidney disease progression. [email protected] 12 11 2018 20 01 2019 7 2 2019 Focal segmental glomerulosclerosis Kidney disease Phosphate Phosphate binder Renal function Inorganic phosphate (Pi...
Journal Articles
Subject Area:
Nephrology
Alastair Hutchison, Andrew Whelton, Ravi Thadhani, Heinrich Achenbach, Andrea Vergani, Jingyang Wu, Gillian Hall
Journal:
Nephron
Nephron (2018) 140 (4): 265–274.
Published Online: 23 October 2018
... who had undergone dialysis for at least 12 consecutive weeks and had been treated with any other phosphate binder formed the primary comparator cohort. A historical cohort was also evaluated. Primary outcomes were all-cause mortality, and time to and incidence of first bone-fracture event requiring...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron
Nephron (1996) 72 (3): 391–394.
Published Online: 18 December 2008
... = 17.8%. There was no significant difference (p > 0.05) between calcium HMB and calcium acetate. These results suggest that calcium HMB is an efficient phosphate binder in vitro, which may predict its effective role in vivo. 17 02 1995 18 12 2008 Uremia Calcium β-hydroxy-β...
Journal Articles
Subject Area:
Nephrology
A. Fournier, Ph. Morinière, R. Oprisiu, P. Yverneau-Hardy, P.F. Westeel, H. Mazouz, N. El Esper, A. Ghazali, B. Boudailliez
Journal:
Nephron
Nephron (1995) 71 (3): 254–283.
Published Online: 18 December 2008
... by the increased phosphate intestinal absorption induced by the 1α(OH)D derivatives) and the consequent possible hyperphosphatemia should be prevented or corrected by the oral administration of alkaline salts of calcium given before the meals as phosphate binders without inducing hypercalcemia. These prerequisites...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron
Nephron (1993) 63 (3): 258–262.
Published Online: 12 December 2008
... acetate Calcium carbonate Phosphate binder Original Paper Nephron 1993;63:258-262 F. Ben Hamida /. El Esper M. Compagnon Ph. Marinière A. Fournier Service de Néphrologie, CHU Amiens, France Long-Term (6 Months) Cross-Over Comparison of Calcium Acetate with Calcium Carbonate as Phosphate Binder Key...
Journal Articles
Subject Area:
Nephrology
P. Morinière, M. Cohen-Solal, S. Belbrik, B. Boudailliez, A. Marie, P.F. Westeel, H. Renaud, P. Fievet, J.D. Lalau, J.L. Sebert, A. Fournier
Journal:
Nephron
Nephron (1989) 53 (2): 93–101.
Published Online: 10 December 2008
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 27 01 1989 10 12 2008 Adynamic bone disease Al(OH) 3 Phosphate binder CaC0 3 Osteomalacia Original Papers Nephron 1989;53:93...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron
Nephron (1988) 50 (4): 345–350.
Published Online: 09 December 2008
...Seiya Okuda; Kenichi Motomura; Toru Sanai; Yukinori Oh; Kaoru Onoyama; Masatoshi Fujishima To investigate the effect of phosphate binder on adriamycin (ADR)-induced nephropathy, serial changes in renal histology and renal hemodynamics were compared between ADR rats treated with aluminum hydroxide...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron
Nephron (1989) 51 (4): 530–535.
Published Online: 09 December 2008
...Toru Sanai; Seiya Okuda; Kenichi Motomura; Kaoru Onoyama; Masatoshi Fujishima To investigate the effect of phosphate binders on the progress of renal functional deterioration, aluminium hydroxide (AL) or calcium carbonate (CA) was administered to adriamycin (ADR)-induced progressive renal failure...
Journal Articles
Subject Area:
Nephrology
Nobuo Nagano, Sonoe Miyata, Sachiko Obana, Nobuaki Eto, Naoshi Fukushima, Steven K. Burke, Michihito Wada
Journal:
Nephron
Nephron (2001) 89 (3): 321–328.
Published Online: 10 October 2001
...Nobuo Nagano; Sonoe Miyata; Sachiko Obana; Nobuaki Eto; Naoshi Fukushima; Steven K. Burke; Michihito Wada The effects of sevelamer hydrochloride (Renagel ® ; hereafter referred to as sevelamer), a noncalcemic phosphate binder, on renal mineral handling were examined in rats. Normal rats were fed...